Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2015, Bioqube Ventures is a global life sciences investment firm with offices in Belgium and the United States. The firm has backed over 20 biotech companies and employs a stage-agnostic investment approach, supporting companies from inception through early clinical milestones. Their focus is on transforming scientific discoveries into medicines that address major unmet medical needs.
Bioqube Ventures invests in companies developing first- or best-in-class therapeutics, primarily in the biotech and healthcare sectors. Their investment strategy includes venture creation, early-stage company building, and selective clinical co-investment. The firm operates globally, with a strong emphasis on disciplined execution and a solid biological rationale in its investments.
Notable portfolio companies include Primmune Therapeutics, engaged in clinical studies for melanoma; CatalYm, focused on developing therapies for cancer treatment; Bicara Therapeutics, known for its breakthrough therapy designation from the U.S. FDA; SynOx Therapeutics, involved in clinical trials for cancer therapies; and Spica Therapeutics, developing macrophage-targeted cancer therapies.
Submit your pitch through their website's contact form at [URL] or email [address] with your deck for consideration.
As of October 2023: Bioqube Ventures has strengthened its leadership team with the appointment of Tessa Ceyssens as Chief Operating Officer. Additionally, Primmune Therapeutics announced the close of its Series B financing, highlighting the firm's active support for its portfolio companies.
Yes, Bioqube Ventures often leads investment rounds, particularly in early-stage biotech companies.
The firm is open to follow-on investments, especially for portfolio companies that demonstrate significant progress and potential in their clinical development.
Specific fund size details are not disclosed, but the firm has a strong track record of backing over 20 companies since its inception.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.